These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1152 related articles for article (PubMed ID: 15070099)
21. PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery. Luong D; Kesharwani P; Deshmukh R; Mohd Amin MCI; Gupta U; Greish K; Iyer AK Acta Biomater; 2016 Oct; 43():14-29. PubMed ID: 27422195 [TBL] [Abstract][Full Text] [Related]
22. Investigations on biodistribution of technetium-99m-labeled carbohydrate-coated poly(propylene imine) dendrimers. Agashe HB; Babbar AK; Jain S; Sharma RK; Mishra AK; Asthana A; Garg M; Dutta T; Jain NK Nanomedicine; 2007 Jun; 3(2):120-7. PubMed ID: 17572354 [TBL] [Abstract][Full Text] [Related]
23. Synthesis, biodistribution, and microsingle photon emission computed tomography (SPECT) imaging study of technetium-99m labeled PEGylated dendrimer poly(amidoamine) (PAMAM)-folic acid conjugates. Zhang Y; Sun Y; Xu X; Zhang X; Zhu H; Huang L; Qi Y; Shen YM J Med Chem; 2010 Apr; 53(8):3262-72. PubMed ID: 20350006 [TBL] [Abstract][Full Text] [Related]
24. Cellular uptake of glucoheptoamidated poly(amidoamine) PAMAM G3 dendrimer with amide-conjugated biotin, a potential carrier of anticancer drugs. Uram Ł; Szuster M; Filipowicz A; Zaręba M; Wałajtys-Rode E; Wołowiec S Bioorg Med Chem; 2017 Jan; 25(2):706-713. PubMed ID: 27919613 [TBL] [Abstract][Full Text] [Related]
25. A Radiolabeled Self-assembled Nanoparticle Probe for Diagnosis of Lung-Metastatic Melanoma. Tanaka T; Sano K; Munekane M; Yamasaki T; Sasaki H; Mukai T Biol Pharm Bull; 2021; 44(3):410-415. PubMed ID: 33642549 [TBL] [Abstract][Full Text] [Related]
26. Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy. Li J; Liang H; Liu J; Wang Z Int J Pharm; 2018 Jul; 546(1-2):215-225. PubMed ID: 29787895 [TBL] [Abstract][Full Text] [Related]
27. Influence of dendrimer generation and polyethylene glycol length on the biodistribution of PEGylated dendrimers. Kojima C; Regino C; Umeda Y; Kobayashi H; Kono K Int J Pharm; 2010 Jan; 383(1-2):293-6. PubMed ID: 19761822 [TBL] [Abstract][Full Text] [Related]
28. Size and Surface Charge of Engineered Poly(amidoamine) Dendrimers Modulate Tumor Accumulation and Penetration: A Model Study Using Multicellular Tumor Spheroids. Bugno J; Hsu HJ; Pearson RM; Noh H; Hong S Mol Pharm; 2016 Jul; 13(7):2155-63. PubMed ID: 26828309 [TBL] [Abstract][Full Text] [Related]
29. Coordination and reduction processes in the synthesis of dendrimer-encapsulated Pt nanoparticles. Yamamoto D; Watanabe S; Miyahara MT Langmuir; 2010 Feb; 26(4):2339-45. PubMed ID: 20141201 [TBL] [Abstract][Full Text] [Related]
30. Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst dendrimers. Roberts JC; Bhalgat MK; Zera RT J Biomed Mater Res; 1996 Jan; 30(1):53-65. PubMed ID: 8788106 [TBL] [Abstract][Full Text] [Related]
31. Differences in toxicity of anionic and cationic PAMAM and PPI dendrimers in zebrafish embryos and cancer cell lines. Bodewein L; Schmelter F; Di Fiore S; Hollert H; Fischer R; Fenske M Toxicol Appl Pharmacol; 2016 Aug; 305():83-92. PubMed ID: 27288734 [TBL] [Abstract][Full Text] [Related]
32. The influence of PAMAM dendrimers surface groups on their interaction with porcine pepsin. Ciolkowski M; Rozanek M; Bryszewska M; Klajnert B Biochim Biophys Acta; 2013 Oct; 1834(10):1982-7. PubMed ID: 23851144 [TBL] [Abstract][Full Text] [Related]
33. PAMAM Dendrimers Cross the Blood-Brain Barrier When Administered through the Carotid Artery in C57BL/6J Mice. Srinageshwar B; Peruzzaro S; Andrews M; Johnson K; Hietpas A; Clark B; McGuire C; Petersen E; Kippe J; Stewart A; Lossia O; Al-Gharaibeh A; Antcliff A; Culver R; Swanson D; Dunbar G; Sharma A; Rossignol J Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335421 [TBL] [Abstract][Full Text] [Related]
34. How to study dendrimers and dendriplexes III. Biodistribution, pharmacokinetics and toxicity in vivo. Shcharbin D; Janaszewska A; Klajnert-Maculewicz B; Ziemba B; Dzmitruk V; Halets I; Loznikova S; Shcharbina N; Milowska K; Ionov M; Shakhbazau A; Bryszewska M J Control Release; 2014 May; 181():40-52. PubMed ID: 24607663 [TBL] [Abstract][Full Text] [Related]
35. Peptide dendrimer-Doxorubicin conjugate-based nanoparticles as an enzyme-responsive drug delivery system for cancer therapy. Zhang C; Pan D; Luo K; She W; Guo C; Yang Y; Gu Z Adv Healthc Mater; 2014 Aug; 3(8):1299-308. PubMed ID: 24706635 [TBL] [Abstract][Full Text] [Related]
36. Development of (177)Lu-DOTA-Dendrimer and Determination of Its Effect on Metal and Ion Levels in Tumor Tissue. Kovacs L; Tassano M; Cabrera M; Zamboni CB; Fernández M; Anjos RM; Cabral P Cancer Biother Radiopharm; 2015 Dec; 30(10):405-9. PubMed ID: 26625257 [TBL] [Abstract][Full Text] [Related]
37. Low systemic toxicity nanocarriers fabricated from heparin-mPEG and PAMAM dendrimers for controlled drug release. Thanh VM; Nguyen TH; Tran TV; Ngoc UP; Ho MN; Nguyen TT; Chau YNT; Le VT; Tran NQ; Nguyen CK; Nguyen DH Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():291-298. PubMed ID: 29025661 [TBL] [Abstract][Full Text] [Related]
40. Toxicology of Engineered Nanoparticles: Focus on Poly(amidoamine) Dendrimers. Naha PC; Mukherjee SP; Byrne HJ Int J Environ Res Public Health; 2018 Feb; 15(2):. PubMed ID: 29443901 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]